Details checkedStrong evidenceCheckedcompany

Tinearity G1 Tinnitus System

Also known as: Tinearity G1, Tinearity, Duearity Tinearity G1

Duearity

Primary source

Company

Duearity

Program Type

Device

Modality

Neuromodulation

Stage

Marketed

Status

Marketed

Target Gene

—

Route / Mode

External adhesive bone-conduction sound generator worn behind the ear

Confidence

86%

Status Confidence

Status confirmed

Evidence Strength

Strong evidence

Last Reviewed

2026-06-10

Geography

Europe, United States

Population

adult, tinnitus

Trial IDs

Mechanism

Non-invasive acoustic neuromodulation and sound-therapy device that delivers white noise through bone conduction while leaving the ear canal open.

Indications

Tinnitus

Notes

Adds a current bone-conduction tinnitus device distinct from Lenire/Auricle; useful for separating tinnitus sound-therapy hardware from hearing-aid masking features.

Evidence & Sources

2 structured sources

company

Supports: canonicalName, aliases, company, programType, modality, mechanism, indications, status...

Open

publication

Supports: stage, geography, notes, keyEvents

Open

Key Events

2023-07-05

Duearity announced U.S. FDA clearance coverage for Tinearity G1

Related Programs

Lenire Tinnitus Treatment Device

Company: Neuromod Devices · Neuromodulation · Marketed

Auricle Tinnitus Device

Company: Auricle Inc. · Neuromodulation · Phase 2

Neuromonics Tinnitus Treatment System

Company: Neuromonics · Neuromodulation · Marketed

Beltone Serene Hearing Aids

Company: Beltone · Hearing Aid/Software · Marketed

Signia Notch Therapy

Company: Signia · Neuromodulation · Marketed

ELEHEAR Beyond Pro OTC Hearing Aids

Company: ELEHEAR · Hearing Aid/Software · Marketed